The trial hypothesis says that a concise medical briefing before SARS-CoV-2 vaccination can reduce the occurence and intensity of vaccination associated adverse effects.
Conditions
Interventions
Group 1: The medical briefing of the control group will be very in-depth. The doctor will precisely adhere to the leaflet („detailed medical briefing“) that had been handed out beforehand with all pos
Sponsors
Impfzentrum Lichtenfels
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Only patients that were willing and able to give consent are included in this study.
Exclusion criteria
Exclusion criteria: Patients that were not willing or unable to give consent were not included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General occurrence of adverse effects, that can be attributed to the vaccination. Specification of the adverse effects that possibly occurred and their intensity. Use of painkillers to reduce the adverse effects and, if yes, specification of the painkiller. Requirement of a doctoral sick note after the vaccination and, if yes, duration of sick leave. These points are queried using an online or offline questionnaire 5 days after the vaccination (multiple choice). | — |
Secondary
| Measure | Time frame |
|---|---|
| Rating of the visit at the Lichtenfels Vaccination Center. Satisfaction with the medical briefing. | — |
Countries
Germany
Contacts
Public ContactNora Beller
Landratsamt Lichtenfels
Outcome results
None listed